Politics and Government Politics and Government

J&J boosts US investments by 25% over 4 years amid looming tariff threats


Published on 2025-03-21 22:00:58 - Reuters
  Print publication without navigation

  • Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a threat of drug import duties by the Trump administration compels companies to expand their manufacturing operations domestically.

Johnson & Johnson (J&J) has announced plans to increase its investments in the United States by 25% over the next four years, amounting to an additional $13 billion. This decision comes in response to potential tariff threats and aims to bolster domestic manufacturing and supply chain resilience. The company, which has been a significant player in the pharmaceutical and medical device sectors, intends to expand its operations in the U.S., focusing on innovation, job creation, and enhancing its production capabilities. This move is part of a broader strategy to navigate the complexities of international trade relations and ensure a stable supply of critical healthcare products amidst global uncertainties.

Read the Full Reuters Article at:
[ https://www.msn.com/en-ca/money/topstories/j-j-boosts-us-investments-by-25-over-4-years-amid-looming-tariff-threats/ar-AA1BoXv6 ]